Aneuploidy prediction and tumor classification with heterogeneous hidden conditional random fields
暂无分享,去创建一个
Edoardo M. Airoldi | Robert E. Schapire | Olga G. Troyanskaya | Zafer Barutçuoglu | Vanessa Dumeaux | R. Schapire | O. Troyanskaya | Zafer Barutçuoglu | E. Airoldi | V. Dumeaux
[1] Peter J. Park,et al. Comparative analysis of algorithms for identifying amplifications and deletions in array CGH data , 2005, Bioinform..
[2] D. Albertson,et al. Gene amplification in cancer. , 2006, Trends in genetics : TIG.
[3] P. Raychaudhuri,et al. Cul 4 A Physically Associates with MDM 2 and Participates in the Proteolysis of p 53 , 2004 .
[4] Marcel J T Reinders,et al. Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. , 2002, Cancer research.
[5] J. Fridlyand,et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma , 2005, Oncogene.
[6] David M. Rocke,et al. A Model for Measurement Error for Gene Expression Arrays , 2001, J. Comput. Biol..
[7] Yu Li,et al. Genomic and functional evidence for an ARID1A tumor suppressor role , 2007, Genes, chromosomes & cancer.
[8] Emmanuel Barillot,et al. Classification of arrayCGH data using fused SVM , 2008, ISMB.
[9] H. Zou,et al. Regularization and variable selection via the elastic net , 2005 .
[10] Ramón Díaz-Uriarte,et al. Flexible and Accurate Detection of Genomic Copy-Number Changes from aCGH , 2007, PLoS Comput. Biol..
[11] Jun Ho Jeon,et al. VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression , 2003, Oncogene.
[12] H. Russnes,et al. Molecular classification of breast carcinomas , 2010 .
[13] Ben Taskar,et al. Max-Margin Markov Networks , 2003, NIPS.
[14] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[15] W. Kuo,et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.
[16] David J Smith,et al. Loss of fibulin-2 expression is associated with breast cancer progression. , 2007, The American journal of pathology.
[17] Christian A. Rees,et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] Michael I. Jordan,et al. Advances in Neural Information Processing Systems 30 , 1995 .
[19] Yuan Qi,et al. Bayesian Conditional Random Fields , 2005, AISTATS.
[20] Lars Hofmann,et al. p73 poses a barrier to malignant transformation by limiting anchorage‐independent growth , 2008, The EMBO journal.
[21] J. Nocedal. Updating Quasi-Newton Matrices With Limited Storage , 1980 .
[22] Michael I. Jordan,et al. Hierarchical Dirichlet Processes , 2006 .
[23] Kevin P. Murphy,et al. Modeling recurrent DNA copy number alterations in array CGH data , 2007, ISMB/ECCB.
[24] F. Mitelman,et al. Primary chromosome abnormalities in human neoplasia. , 1989, Advances in cancer research.
[25] Yongdai Kim,et al. Gradient LASSO for feature selection , 2004, ICML.
[26] Stephen Chia,et al. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. , 2006, Gynecologic oncology.
[27] Ajay N. Jain,et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.
[28] G. Tian,et al. Statistical Applications in Genetics and Molecular Biology Sparse Logistic Regression with Lp Penalty for Biomarker Identification , 2011 .
[29] P. Nederlof,et al. Array-CGH and breast cancer , 2006, Breast Cancer Research.
[30] Sun-Yuan Kung,et al. Accurate detection of aneuploidies in array CGH and gene expression microarray data , 2004, Bioinform..
[31] Tara L. Naylor,et al. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. , 2005, Cancer research.
[32] P. Raychaudhuri,et al. Cul4A Physically Associates with MDM2 and Participates in the Proteolysis of p53 , 2004, Cancer Research.